全文获取类型
收费全文 | 16798篇 |
免费 | 1676篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 147篇 |
儿科学 | 491篇 |
妇产科学 | 314篇 |
基础医学 | 2146篇 |
口腔科学 | 260篇 |
临床医学 | 2178篇 |
内科学 | 3324篇 |
皮肤病学 | 203篇 |
神经病学 | 1577篇 |
特种医学 | 486篇 |
外科学 | 2310篇 |
综合类 | 766篇 |
一般理论 | 16篇 |
预防医学 | 1645篇 |
眼科学 | 422篇 |
药学 | 1138篇 |
中国医学 | 10篇 |
肿瘤学 | 1072篇 |
出版年
2023年 | 105篇 |
2022年 | 171篇 |
2021年 | 528篇 |
2020年 | 312篇 |
2019年 | 423篇 |
2018年 | 551篇 |
2017年 | 358篇 |
2016年 | 337篇 |
2015年 | 409篇 |
2014年 | 507篇 |
2013年 | 810篇 |
2012年 | 960篇 |
2011年 | 987篇 |
2010年 | 555篇 |
2009年 | 432篇 |
2008年 | 746篇 |
2007年 | 795篇 |
2006年 | 832篇 |
2005年 | 735篇 |
2004年 | 675篇 |
2003年 | 621篇 |
2002年 | 593篇 |
2001年 | 495篇 |
2000年 | 469篇 |
1999年 | 434篇 |
1998年 | 171篇 |
1997年 | 144篇 |
1996年 | 173篇 |
1995年 | 157篇 |
1994年 | 103篇 |
1993年 | 137篇 |
1992年 | 322篇 |
1991年 | 308篇 |
1990年 | 320篇 |
1989年 | 263篇 |
1988年 | 232篇 |
1987年 | 256篇 |
1986年 | 205篇 |
1985年 | 179篇 |
1984年 | 176篇 |
1983年 | 142篇 |
1982年 | 103篇 |
1981年 | 68篇 |
1980年 | 69篇 |
1979年 | 123篇 |
1978年 | 106篇 |
1977年 | 85篇 |
1975年 | 76篇 |
1973年 | 69篇 |
1970年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 343 毫秒
1.
E. M. Peterman C. Sullivan M. F. Goody I. Rodriguez-Nunez J. A. Yoder C. H. Kim 《Infection and immunity》2015,83(1):430-440
Mitochondria are known primarily as the location of the electron transport chain and energy production in cells. More recently, mitochondria have been shown to be signaling centers for apoptosis and inflammation. Reactive oxygen species (ROS) generated as by-products of the electron transport chain within mitochondria significantly impact cellular signaling pathways. Because of the toxic nature of ROS, mitochondria possess an antioxidant enzyme, superoxide dismutase 2 (SOD2), to neutralize ROS. If mitochondrial antioxidant enzymes are overwhelmed during severe infections, mitochondrial dysfunction can occur and lead to multiorgan failure or death. Pseudomonas aeruginosa is an opportunistic pathogen that can infect immunocompromised patients. Infochemicals and exotoxins associated with P. aeruginosa are capable of causing mitochondrial dysfunction. In this work, we describe the roles of SOD2 and mitochondrial ROS regulation in the zebrafish innate immune response to P. aeruginosa infection. sod2 is upregulated in mammalian macrophages and neutrophils in response to lipopolysaccharide in vitro, and sod2 knockdown in zebrafish results in an increased bacterial burden. Further investigation revealed that phagocyte numbers are compromised in Sod2-deficient zebrafish. Addition of the mitochondrion-targeted ROS-scavenging chemical MitoTEMPO rescues neutrophil numbers and reduces the bacterial burden in Sod2-deficient zebrafish. Our work highlights the importance of mitochondrial ROS regulation by SOD2 in the context of innate immunity and supports the use of mitochondrion-targeted ROS scavengers as potential adjuvant therapies during severe infections. 相似文献
2.
Familial risk and heritability of intellectual disability: a population-based cohort study in Sweden
3.
4.
5.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献
6.
7.
8.
S Kyle R S Stubbs R J Stewart 《The Australian and New Zealand journal of surgery》1988,58(11):895-898
Choledochal cyst is an unusual but serious condition which most commonly affects Oriental people. Recent experience of three patients with this condition in whom diagnosis was made by ultrasound examination is reported. Cholangiography (ERCP or PTC) was performed in two of the cases to define the anatomy. All three cases were successfully managed by cyst excision and biliary reconstruction by Roux-en-Y hepaticojejunostomy. The rationale for and importance of cyst excision are discussed. 相似文献
9.
10.